vs

Side-by-side financial comparison of Genius Sports Ltd (GENI) and PROASSURANCE CORP (PRA). Click either name above to swap in a different company.

Genius Sports Ltd is the larger business by last-quarter revenue ($510.9M vs $269.6M, roughly 1.9× PROASSURANCE CORP). PROASSURANCE CORP runs the higher net margin — 12.4% vs -12.3%, a 24.7% gap on every dollar of revenue. Over the past eight quarters, Genius Sports Ltd's revenue compounded faster (129.2% CAGR vs -2.7%).

Genius Sports is a sports data and technology company that provides data management, video streaming and integrity services to sports leagues, bookmakers and media companies.

ProAssurance Corporation, headquartered in Birmingham, Alabama, is a property and casualty company that sells professional liability insurance to doctors. The company was founded in 1976 as Mutual Assurance and was later renamed to Medical Assurance in 1997. The name "ProAssurance" was created in 2001 when Medical Assurance merged with Professionals Group. The company is currently the fourth largest medical professional liability insurance writer and has over $6 billion in assets.

GENI vs PRA — Head-to-Head

Bigger by revenue
GENI
GENI
1.9× larger
GENI
$510.9M
$269.6M
PRA
Higher net margin
PRA
PRA
24.7% more per $
PRA
12.4%
-12.3%
GENI
Faster 2-yr revenue CAGR
GENI
GENI
Annualised
GENI
129.2%
-2.7%
PRA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GENI
GENI
PRA
PRA
Revenue
$510.9M
$269.6M
Net Profit
$-63.0M
$33.4M
Gross Margin
25.2%
Operating Margin
-11.5%
17.3%
Net Margin
-12.3%
12.4%
Revenue YoY
-7.1%
Net Profit YoY
106.4%
EPS (diluted)
$0.65

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GENI
GENI
PRA
PRA
Q4 25
$510.9M
$269.6M
Q3 25
$335.4M
$279.6M
Q2 25
$215.2M
$276.8M
Q1 25
$119.7M
$272.1M
Q4 24
$413.0M
$290.1M
Q3 24
$285.8M
$285.3M
Q2 24
$184.1M
$290.4M
Q1 24
$97.2M
$284.7M
Net Profit
GENI
GENI
PRA
PRA
Q4 25
$-63.0M
$33.4M
Q3 25
$1.4M
Q2 25
$-47.3M
$21.9M
Q1 25
$-25.5M
$-5.8M
Q4 24
$-85.5M
$16.2M
Q3 24
$-47.1M
$16.4M
Q2 24
$-35.5M
$15.5M
Q1 24
$-25.2M
$4.6M
Gross Margin
GENI
GENI
PRA
PRA
Q4 25
25.2%
Q3 25
24.2%
Q2 25
19.1%
Q1 25
10.7%
Q4 24
16.7%
Q3 24
20.5%
Q2 24
18.6%
Q1 24
9.8%
Operating Margin
GENI
GENI
PRA
PRA
Q4 25
-11.5%
17.3%
Q3 25
-15.3%
1.6%
Q2 25
-21.0%
9.9%
Q1 25
-20.3%
-2.3%
Q4 24
-18.0%
6.5%
Q3 24
-13.9%
7.4%
Q2 24
-16.8%
6.2%
Q1 24
-23.7%
1.9%
Net Margin
GENI
GENI
PRA
PRA
Q4 25
-12.3%
12.4%
Q3 25
0.5%
Q2 25
-22.0%
7.9%
Q1 25
-21.3%
-2.1%
Q4 24
-20.7%
5.6%
Q3 24
-16.5%
5.8%
Q2 24
-19.3%
5.3%
Q1 24
-25.9%
1.6%
EPS (diluted)
GENI
GENI
PRA
PRA
Q4 25
$0.65
Q3 25
$0.03
Q2 25
$0.42
Q1 25
$-0.11
Q4 24
$0.32
Q3 24
$0.32
Q2 24
$0.30
Q1 24
$0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GENI
GENI
PRA
PRA
Cash + ST InvestmentsLiquidity on hand
$280.6M
$36.5M
Total DebtLower is stronger
$420.4M
Stockholders' EquityBook value
$724.5M
$1.3B
Total Assets
$1.1B
$5.4B
Debt / EquityLower = less leverage
0.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GENI
GENI
PRA
PRA
Q4 25
$280.6M
$36.5M
Q3 25
$110.2M
$54.5M
Q2 25
$110.2M
$41.6M
Q1 25
$110.2M
$43.5M
Q4 24
$100.3M
$54.9M
Q3 24
$100.3M
$45.3M
Q2 24
$100.3M
$36.9M
Q1 24
$100.3M
$65.4M
Total Debt
GENI
GENI
PRA
PRA
Q4 25
$420.4M
Q3 25
$421.5M
Q2 25
$422.6M
Q1 25
$423.7M
Q4 24
$424.9M
Q3 24
$425.9M
Q2 24
$426.9M
Q1 24
$427.8M
Stockholders' Equity
GENI
GENI
PRA
PRA
Q4 25
$724.5M
$1.3B
Q3 25
$572.4M
$1.3B
Q2 25
$572.4M
$1.3B
Q1 25
$572.4M
$1.2B
Q4 24
$573.0M
$1.2B
Q3 24
$573.0M
$1.2B
Q2 24
$573.0M
$1.1B
Q1 24
$573.0M
$1.1B
Total Assets
GENI
GENI
PRA
PRA
Q4 25
$1.1B
$5.4B
Q3 25
$792.3M
$5.6B
Q2 25
$792.3M
$5.5B
Q1 25
$792.3M
$5.5B
Q4 24
$775.7M
$5.6B
Q3 24
$775.7M
$5.7B
Q2 24
$775.7M
$5.6B
Q1 24
$775.7M
$5.7B
Debt / Equity
GENI
GENI
PRA
PRA
Q4 25
0.31×
Q3 25
0.32×
Q2 25
0.33×
Q1 25
0.34×
Q4 24
0.35×
Q3 24
0.35×
Q2 24
0.38×
Q1 24
0.38×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GENI
GENI
PRA
PRA
Operating Cash FlowLast quarter
$81.9M
$-25.6M
Free Cash FlowOCF − Capex
$69.6M
FCF MarginFCF / Revenue
13.6%
Capex IntensityCapex / Revenue
2.4%
Cash ConversionOCF / Net Profit
-0.77×
TTM Free Cash FlowTrailing 4 quarters
$33.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GENI
GENI
PRA
PRA
Q4 25
$81.9M
$-25.6M
Q3 25
$-4.8M
$27.2M
Q2 25
$-1.2M
$-28.1M
Q1 25
$-14.6M
$-11.6M
Q4 24
$14.9M
$-10.7M
Q3 24
$-9.2M
$14.0M
Q2 24
$-12.8M
Q1 24
$-11.6M
Free Cash Flow
GENI
GENI
PRA
PRA
Q4 25
$69.6M
Q3 25
$-14.2M
Q2 25
$-5.8M
Q1 25
$-16.0M
Q4 24
$11.3M
Q3 24
$-11.6M
Q2 24
Q1 24
FCF Margin
GENI
GENI
PRA
PRA
Q4 25
13.6%
Q3 25
-4.2%
Q2 25
-2.7%
Q1 25
-13.4%
Q4 24
2.7%
Q3 24
-4.1%
Q2 24
Q1 24
Capex Intensity
GENI
GENI
PRA
PRA
Q4 25
2.4%
Q3 25
2.8%
Q2 25
2.1%
Q1 25
1.2%
Q4 24
0.9%
Q3 24
0.9%
Q2 24
Q1 24
Cash Conversion
GENI
GENI
PRA
PRA
Q4 25
-0.77×
Q3 25
18.81×
Q2 25
-1.28×
Q1 25
Q4 24
-0.66×
Q3 24
0.85×
Q2 24
-0.83×
Q1 24
-2.52×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GENI
GENI

Segment breakdown not available.

PRA
PRA

Workers Compensation Insurance Segment$164.4M61%
Other$59.6M22%
Segregated Portfolio Cell Reinsurance$45.7M17%

Related Comparisons